SHINPOONG PHARMACEUTICAL CO.,LTD
Develops and manufactures pharmaceuticals, APIs, and medical devices for global markets.
019170 | KO
Overview
Corporate Details
- ISIN(s):
- KR7019170000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 안산시 단원구 원시로 7, 안산시
- Sector:
- Manufacturing
Description
SHINPOONG PHARMACEUTICAL CO.,LTD. is a research and development-oriented pharmaceutical company that manufactures and markets a wide range of pharmaceutical products and active pharmaceutical ingredients (APIs). The company's portfolio includes finished products such as cephalosporin and penicillin antibiotics, antivirals, anticancer drugs, and painkillers. It also develops and supplies medical devices, including Medicurtain, an anti-adhesion barrier. The company manages the entire production process from raw materials to finished goods, serving both domestic and international markets.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-01-03 00:00 |
횡령ㆍ배임혐의발생
|
Korean | 9.3 KB | ||
| 2022-12-19 00:00 |
기타시장안내
|
Korean | 5.8 KB | ||
| 2022-12-16 00:00 |
풍문또는보도에대한해명(미확정)
|
Korean | 9.7 KB | ||
| 2022-11-29 00:00 |
풍문또는보도에대한해명(미확정)
|
Korean | 9.9 KB | ||
| 2022-11-21 00:00 |
풍문또는보도에대한해명(미확정)
|
Korean | 8.9 KB | ||
| 2022-11-15 00:00 |
투자판단관련주요경영사항
|
Korean | 9.1 KB | ||
| 2022-11-14 00:00 |
분기보고서 (2022.09)
|
Korean | 1.7 MB | ||
| 2022-11-09 00:00 |
투자판단관련주요경영사항
|
Korean | 17.3 KB | ||
| 2022-09-27 00:00 |
[기재정정]투자판단관련주요경영사항(COVID-19 치료제 피라맥스정의 임상 3상 시험계획 영국 승인)
|
Korean | 24.3 KB | ||
| 2022-08-22 00:00 |
풍문또는보도에대한해명(미확정)
|
Korean | 8.1 KB | ||
| 2022-08-16 00:00 |
반기보고서 (2022.06)
|
Korean | 1.7 MB | ||
| 2022-08-12 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 8.4 KB | ||
| 2022-07-07 00:00 |
[기재정정]투자판단관련주요경영사항(COVID-19 치료제 피라맥스정의 임상 3상 시험계획 영국 승인)
|
Korean | 24.3 KB | ||
| 2022-06-24 00:00 |
풍문또는보도에대한해명(미확정)
|
Korean | 7.6 KB | ||
| 2022-06-13 00:00 |
[기재정정]투자판단관련주요경영사항(COVID-19 치료제 피라맥스정의 임상 3상 시험계획 영국 승인)
|
Korean | 24.3 KB |
Automate Your Workflow. Get a real-time feed of all SHINPOONG PHARMACEUTICAL CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SHINPOONG PHARMACEUTICAL CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SHINPOONG PHARMACEUTICAL CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
